Cargando…
mRNA-based modalities for infectious disease management
The novel coronavirus disease 2019 (COVID-19) is still rampant all over the world, causing incalculable losses to the world. Major pharmaceutical organizations around the globe are focusing on vaccine research and drug development to prevent further damage caused by the pandemic. The messenger RNA (...
Autores principales: | Zhang, Mengjie, Hussain, Abid, Yang, Haiyin, Zhang, Jinchao, Liang, Xing-Jie, Huang, Yuanyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tsinghua University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258466/ https://www.ncbi.nlm.nih.gov/pubmed/35818566 http://dx.doi.org/10.1007/s12274-022-4627-5 |
Ejemplares similares
-
mRNA vaccines for COVID-19 and diverse diseases
por: Hussain, Abid, et al.
Publicado: (2022) -
Efficient hepatic delivery and protein expression enabled by optimized mRNA and ionizable lipid nanoparticle
por: Yang, Tongren, et al.
Publicado: (2020) -
Exosome regulation of immune response mechanism: Pros and cons in immunotherapy
por: Essola, Julien Milon, et al.
Publicado: (2023) -
Advances in mRNA Vaccines for Infectious Diseases
por: Zhang, Cuiling, et al.
Publicado: (2019) -
Membrane‐destabilizing ionizable lipid empowered imaging‐guided siRNA delivery and cancer treatment
por: Guo, Shuai, et al.
Publicado: (2021)